Knowledge Center

Patent / Jan 01, 1984

Rhodium-containing catalysts and their application

Authors:
  • Philip Page
Source:
EP 86046

A catalyst for hydrogenating tetracycline intermediates was prepd. by treating a Rh phosphine complex with a hydrazine. Thus (Ph3P)3RhCl was treated with N2H4 to give a catalyst contg. 16.95% Rh which was used together with PPh3 to hydrogenate I (RR1 = CH2) to give I (R = Me, R1 = H) free from epimer.

Also in the Knowledge Center

Related Content

Dispersome®

Make your drug soluble with Dispersome® technology. Dispersome® is a solubility enhancement technology that relies on an innovative and naturally occurring excipient to develop amorphous solid dispersions with high drug loading and high bioavailability.

Page
Read more

Drug delivery platforms

Hovione has unique capabilities and expertise in solubility enhancement, lung delivery, modified release and taste-masking applications.

Page
Read more

Speak Up!

An Ethics Line to enable team members to Speak Up!

Page
Read more